$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Improved probes using nucleosides containing 3-dezauracil analogs 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C12P-019/34
  • C12Q-001/68
  • C07H-017/00
출원번호 US-0400205 (1989-08-29)
발명자 / 주소
  • Rogers Thomas E. (Manchester MO) Gray Steven H. (Ellisville MO) Devadas Balekudru (Chesterfield MO) Adams Steven P. (St. Charles MO)
출원인 / 주소
  • Monsanto Company (St. Louis MO 02)
인용정보 피인용 횟수 : 263  인용 특허 : 0

초록

The deazauracil containing probes of the invention are able to withstand higher temperatures, thereby allowing unmatched probes and mismatched probes to be washed off at higher hybridization stringency, thereby eliminating background readings and improving ease and accuracy of probe use.

대표청구항

A single-stranded nucleic acid probe which comprises a nucleoside residue of the formula: [Figure] in which R1 and R2 independently are C1-C5 alkyl, C2-C5 alkenyl, halo or hydrogen, R3 is hydrogen, hydroxy, C6-14 aryloxy or C1-C5 alkoxy and in which the nucleoside residue is at least five nucleoside

이 특허를 인용한 특허 (263)

  1. Manoharan Muthiah ; Kawasaki Andrew M. ; Cook Phillip Dan ; Fraser Allister S. ; Prakash Thazha P., 2'-O-acetamido modified monomers and oligomers.
  2. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-O-modified oligonucleotides.
  3. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  4. Cook Phillip Dan ; Kawasaki Andrew Mamoru, 2'-modified oligonucleotides.
  5. Cook, Phillip Dan; Kawasaki, Andrew Mamoru, 2'modified oligonucleotides.
  6. Prakash, Thazha P.; Baker, Brenda F.; Eldrup, Anne B.; Manoharan, Muthiah; Bhat, Balkrishen; Griffey, Richard; Swayze, Eric E.; Crooke, Stanley T., 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations.
  7. Baryza, Jeremy Lee; Blommers, Marcel; Fernandez, Cesar; Geno, Erin; Gossert, Alvar; Greenidge, Paulette; Huesken, Dieter; Hunziker, Juerg; Natt, Francois Jean-Charles; Patnaik, Anup; Patterson, Andrew; Rondeau, Jean-Michel Rene; Weiler, Jan; Zhu, Meicheng, 3′end caps for RNAi agents for use in RNA interference.
  8. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5'-modified bicyclic nucleic acid analogs.
  9. Eaton Bruce (SW. 460 Jones Rd. Pullman ; Whitman Co. WA 99163), 5-modified pyrimidines from palladium catalyzed carbon-carbon coupling.
  10. Rohloff, John; Janjic, Nebojsa; Carter, Jeffrey D.; Fowler, Catherine, 5-position modified pyrimidines and their use.
  11. Rohloff, John; Janjic, Nebojsa; Carter, Jeffrey D.; Fowler, Catherine, 5-position modified pyrimidines and their use.
  12. Swayze, Eric E.; Prakash, Thazha P., 5′ and 2′ BIS-substituted nucleosides and oligomeric compounds prepared therefrom.
  13. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  14. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  15. Seth, Punit P.; Swayze, Eric E.; Bhat, Balkrishen, 5′-modified bicyclic nucleic acid analogs.
  16. Seth, Punit P.; Swayze, Eric E., 6-disubstituted or unsaturated bicyclic nucleic acid analogs.
  17. Seth, Punit P.; Swayze, Eric E., 6-modified bicyclic nucleic acid analogs.
  18. Seth, Punit P.; Swayze, Eric E., 6-modified bicyclic nucleic acid analogs.
  19. Seth,Punit P.; Swayze,Eric E., 6-modified bicyclic nucleic acid analogs.
  20. Hope, Michael J.; Semple, Sean C.; Chen, Jianxin; Madden, Thomas D.; Cullis, Pieter R.; Ciufolini, Marco A.; Mui, Barbara Low Shoud, Amino lipids and methods for the delivery of nucleic acids.
  21. Manoharan, Muthiah; Cook, Phillip Dan; Prakash, Thazha P.; Kawasaki, Andrew M., Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom.
  22. Cairns, Belinda; Chen, Ruihuan; Frantz, Gretchen; Hillan, Kenneth J.; Koeppen, Hartmut; Phillips, Heidi S.; Polakis, Paul; Spencer, Susan D.; Smith, Victoria; Williams, P. Mickey; Wu, Thomas D.; Zhang, Zemin, Anti-TAT188 antibodies.
  23. Cairns, Belinda; Chen, Ruihuan; Frantz, Gretchen; Hillan, Kenneth J.; Koeppen, Hartmut; Phillips, Heidi S.; Polakis, Paul; Spencer, Susan D.; Smith, Victoria; Williams, P. Mickey; Wu, Thomas D.; Zhang, Zemin; Sakanaka, Chie; Chuntharapai, Anan; Reed, Chae Janeka, Antibody compositions for the diagnosis and treatment of tumor.
  24. Karelson, Mati; Saarma, Mart; Pilv, Mehis, Antisense agents combining strongly bound base-modified oligonucleotide and artificial nuclease.
  25. Freier, Susan M.; Rigo, Frank, Antisense compounds targeting genes associated with fibronectin.
  26. Freier, Susan M.; Rigo, Frank; Dockrell, Mark; Heidibrecht, Felicia, Antisense compounds targeting genes associated with fibronectin.
  27. Hastings, Michelle L.; Rigo, Frank; Bennett, C. Frank, Antisense compounds targeting genes associated with usher syndrome.
  28. Armstrong, Dustin D., Antisense conjugates for decreasing expression of DMPK.
  29. Armstrong, Dustin D., Antisense conjugates for decreasing expression of DMPK.
  30. David J. Ecker ; Phillip Dan Cook ; Brett P. Monia ; Susan M. Freier ; Yogesh S. Sanghvi, Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
  31. Ecker David J. ; Cook Phillip Dan ; Monia Brett P. ; Freier Susan M. ; Sanghvi Yogesh S., Antisense inhibition of ras gene with chimeric and alternating oligonucleotides.
  32. Bennett, C. Frank; Cowsert, Lex M.; Siwkowski, Andrew M., Antisense modulation of CD40 expression.
  33. Hastings, Michelle L, Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome.
  34. McNally, Elizabeth, Antisense polynucleotides to induce exon skipping and methods of treating dystrophies.
  35. McNally, Elizabeth, Antisense polynucleotides to induce exon skipping and methods of treating dystrophies.
  36. Shimizu, Mamoru; Wada, Takeshi, Asymmetric auxiliary group.
  37. Shimizu, Mamoru; Wada, Takeshi, Asymmetric auxiliary group.
  38. Edinger, Aimee; Hanessian, Stephen, Azacyclic constrained analogs of FTY720.
  39. Bornhop, Darryl J.; Mousa, Mina; Kussrow, Amanda, Backscattering interferometric methods.
  40. Allerson, Charles; Bhat, Balkrishen; Swayze, Eric E., Base modified bicyclic nucleosides and oligomeric compounds prepared therefrom.
  41. Seth, Punit P.; Swayze, Eric E., Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom.
  42. Seth, Punit P.; Migawa, Michael T.; Swayze, Eric E.; Song, Quanlai; Han, Mingming; Ross, Bruce S., Bicyclic cyclohexitol nucleic acid analogs.
  43. Migawa, Michael T.; Seth, Punit P.; Swayze, Eric E.; Ross, Bruce S.; Song, Quanlai; Han, Mingming, Bicyclic cyclohexose nucleic acid analogs.
  44. Seth, Punit P.; Swayze, Eric E., Bicyclic morpholino compounds and oligomeric compounds prepared therefrom.
  45. Seth, Punit P.; Swayze, Eric E.; Hanessian, Stephen; Schroeder, Benjamin R., Bicyclic nucleosides and oligomeric compounds prepared therefrom.
  46. Mirkin, Chad A.; Calabrese, Colin Michael; Briley, William E.; Merkel, Timothy J., Biocompatible infinite coordination polymer nanoparticle-nucleic acid conjugates for antisense gene regulation.
  47. Seth, Punit P.; Swayze, Eric E., Bis-modified bicyclic nucleic acid analogs.
  48. Seth, Punit P.; Swayze, Eric E., Bis-modified bicyclic nucleic acid analogs.
  49. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  50. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  51. Cook Phillip Dan ; Manoharan Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  52. Cook, Phillip Dan; Manoharan, Muthiah, Carbamate-derivatized nucleosides and oligonucleosides.
  53. Seth, Punit P.; Swayze, Eric E., Carbocyclic bicyclic nucleic acid analogs.
  54. Crooke, Stanley T., Chimeric oligomeric compounds and their use in gene modulation.
  55. Butler, David; Iwamoto, Naoki; Meena; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral control.
  56. Butler, David; Iwamoto, Naoki; Meena; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral control.
  57. Meena; Butler, David; Iwamoto, Naoki; Svrzikapa, Nenad; Verdine, Gregory L.; Zlatev, Ivan, Chiral design.
  58. Gemba, Takefumi, Chiral nucleic acid adjuvant.
  59. Gemba, Takefumi; Nagata, Ryoichi; Torikai, Yusuke, Chiral nucleic acid adjuvant having antitumor effect and antitumor agent.
  60. Gemba, Takefumi; Nagata, Ryoichi; Shiga, Ikumi, Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator.
  61. Krotz, Achim; Capaldi, Daniel C.; Gaus, Hans-Joachim Josef; Turney, Brett, Chloral-free DCA in oligonucleotide synthesis.
  62. Krotz,Achim; Capaldi,Daniel; Gaus,Hans; Turney,Brett, Chloral-free DCA in oligonucleotide synthesis.
  63. Liang, Xue-hai; Crooke, Stanley T., Competitive modulation of microRNAs.
  64. Evriklia, Lianidou; Stathopoulou, Aliki; Mavroudis, Dimitrios; Georgoulias, Vasileios, Composition and method for determination of CK19 expression.
  65. Bennett, Clarence Frank; Ecker, David J.; Cook, Phillip Dan, Composition and methods for the pulmonary delivery of nucleic acids.
  66. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Compositions and methods.
  67. Boylan, John Frederick; Bramlage, Birgit; Hossbach, Markus; Reidhaar-Olson, John, Compositions and methods for inhibiting expression of RRM2 genes.
  68. Boylan, John Frederick; Bramlage, Birgit; Hossbach, Markus; Reidhaar-Olson, John, Compositions and methods for inhibiting expression of RRM2 genes.
  69. Wooddell, Christine I; Lewis, David L; Wakefield, Darren H; Almeida, Lauren; Kanner, Steven B, Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin.
  70. Chin, Daniel; Deckert, Jochen; Hossbach, Markus; John, Matthias, Compositions and methods for inhibiting gene expression of hepatitis B virus.
  71. Li, Dean; Jones, Christopher; London, Nyall, Compositions and methods for inhibiting vascular permeability.
  72. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Compositions and methods for modulating HBV expression.
  73. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Compositions and methods for modulating HBV expression.
  74. Rigo, Frank; Freier, Susan M., Compositions and methods for modulating Tau expression.
  75. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Freier, Susan M.; Graham, Mark J.; Crooke, Rosanne M., Compositions and methods for modulating angiopoietin-like 3 expression.
  76. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Freier, Susan M.; Graham, Mark J.; Crooke, Rosanne M., Compositions and methods for modulating angiopoietin-like 3 expression.
  77. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Graham, Mark J., Compositions and methods for modulating apolipoprotein (a) expression.
  78. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Graham, Mark J., Compositions and methods for modulating apolipoprotein (a) expression.
  79. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Graham, Mark J., Compositions and methods for modulating apolipoprotein C-III expression.
  80. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Graham, Mark J., Compositions and methods for modulating apolipoprotein C-III expression.
  81. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E.; Bhanot, Sanjay; Freier, Susan M.; Bui, Huynh-Hoa, Compositions and methods for modulating growth hormone receptor expression.
  82. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  83. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  84. Teng, Ching-Leou; Cook, Phillip Dan; Tillman, Lloyd; Hardee, Gregory E.; Ecker, David J.; Manoharan, Muthiah, Compositions and methods for non-parenteral delivery of oligonucleotides.
  85. Mehta, Rahul C.; Hardee, Gregory E.; Cook, Phillip Dan; Ecker, David J.; Tsai, Yali Jennifer; Templin, Michael V., Compositions and methods for topical delivery of oligonucleotides.
  86. Li, Dean; Jones, Christopher; London, Nyall, Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability.
  87. Dobie, Kenneth W.; Dean, Nicholas M.; Bennett, C. Frank, Compositions and their uses directed to HBXIP.
  88. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2'-modified nucleosides for use in gene modulation.
  89. Allerson, Charles; Bhat, Balkrishen; Eldrup, Anne B.; Manoharan, Muthiah; Griffey, Richard H.; Baker, Brenda F.; Swayze, Eric E., Compositions comprising alternating 2′-modified nucleosides for use in gene modulation.
  90. Freier, Susan M., Compositions for modulating Tau expression.
  91. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression ApoB.
  92. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of DGAT2.
  93. Bhanot, Sanjay; Geary, Richard; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCCR.
  94. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of GCGR.
  95. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Compounds and methods for modulating expression of SGLT2.
  96. Rigo, Frank; Bennett, C. Frank; Krainer, Adrian R.; Hua, Yimin, Compounds and methods for modulating interaction between proteins and target nucleic acids.
  97. Bhat, Balkrishen; Xia, Jie; Seth, Punit P.; Vasquez, Guillermo; Migawa, Michael T.; Allerson, Charles; Prakash, Thazha P.; Swayze, Eric E., Compounds and methods for synthesis of bicyclic nucleic acid analogs.
  98. Capaldi,Daniel C.; Gaus,Hans Joachim Josef; Rentel,Claus Andre Frank; Olsen,Philip Dmitri; Kurata,Christine C.; Song,Quanlai, Compounds and methods for the characterization of oligonucleotides.
  99. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Conjugated antisense compounds and their use.
  100. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Conjugated antisense compounds and their use.
  101. Bennett, C. Frank; McKay, Robert; Monia, Brett P.; Baker, Brenda F.; Sioufi, Namir, Conjugates for use in hepatocyte free uptake assays.
  102. Satterfield, Brent C., Cooperative primers, probes, and applications thereof.
  103. Seth, Punit P.; Swayze, Eric E., Cyclohexenyl nucleic acids analogs.
  104. Seth, Punit P.; Swayze, Eric E., Cyclohexenyl nucleic acids analogs.
  105. Rohloff, John; Janjic, Nebojsa; Gawande, Bharat Nathu, Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto.
  106. Rohloff, John; Janjic, Nebojsa; Gawande, Bharat Nathu, Cytidine-5-carboxamide modified nucleotide compositions and methods related thereto.
  107. Mirkin, Chad A.; Paller, Amy S.; Giljohann, David A., Delivery of oligonucleotide functionalized nanoparticles.
  108. Kumar, Gyanendra; Abarzua, Patricio; Egholm, Michael, Detection method using dissociated rolling circle amplification.
  109. Carvalho,Maria da Gloria; Sampson,Jacquelyn S.; Ades,Edwin W.; Carlone,George; McCaustland,Karen, Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease.
  110. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Diagnosis and treatment of disease.
  111. Regan, John; Cooper, Samantha; So, Austin; Koehler, Ryan; Montesclaros, Luz, Digital assays for mutation detection.
  112. Baker, Brenda F.; Kraynack, Bryan A., Double stranded constructs comprising one or more short strands hybridized to a longer strand.
  113. Rose, Scott D.; Walder, Joseph A.; Beltz, Kristin; Allen, Shawn, Efficient and rapid method for assembling and cloning double-stranded DNA fragments.
  114. Leeds Janet M. ; Cummins Lendell L., Fluorescence based nuclease assay.
  115. Baryza, Jeremy Lee; Blommers, Marcel; Chutkow, William; Fernandez, Cesar; Geno, Erin; Gossert, Alvar; Greenidge, Paulette; Huesken, Dieter; Hunziker, Juerg; Natt, Francois Jean-Charles; Patnaik, Anup; Patterson, Andrew; Rondeau, Jean-Michel Rene; Weiler, Jan; Zhu, Meicheng, Formats for organic compounds for use in RNA interference.
  116. Cook Phillip Dan ; Monia Brett P., Gapped 2' modified oligonucleotides.
  117. Cook Phillip Dan ; Monia Brett P., Gapped 2' modified oligonucleotides.
  118. Cook Phillip Dan ; Monia Brett P., Gapped 2' modified oligonucleotides.
  119. Cook Phillip Dan, Gapped 2'-modified oligonucleotides.
  120. Oestergaard, Michael; Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Gapped oligomeric compounds comprising 5′-modified deoxyribonucleosides in the gap and uses thereof.
  121. Swayze, Eric E.; Migawa, Michael T.; Wyrzykiewicz, Tadeusz Krzysztof, Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini.
  122. Sanghvi, Yogesh S.; Manoharan, Muthiah, Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages.
  123. Cook,Phillip Dan; Monia,Brett P., Gapped oligonucleotides.
  124. Ecker, David J.; Buchardt, Ole; Egholm, Michael; Nielsen, Peter E.; Berg, Rolf H.; Mollegaard, Niels E., Higher order structure and binding of peptide nucleic acids.
  125. Metelev Valeri (Shrewsbury MA) Agrawal Sudhir (Shrewsbury MA), Hybrid oligonucleotide phosphorothioates.
  126. Metelev Valeri,RUX ; Agrawal Sudhir, Hybrid oligonucleotide phosphorothioates.
  127. Metelev, Valeri; Agrawal, Sudhir, Hybrid oligonucleotide phosphorothioates.
  128. Metelev,Valeri; Agrawal,Sudhir, Hybrid oligonucleotide phosphorothioates.
  129. Manoharan, Muthiah, Ligand-conjugated oligomeric compounds.
  130. Wan, W. Brad; Migawa, Michael T.; Oestergaard, Michael; Swayze, Eric E.; Seth, Punit P., Linkage modified oligomeric compounds.
  131. Michael Egholm ; Peter Nielsen DK; Ole Buchardt DK; Kim L. Dueholm DK; Leif Christensen DK; James M. Coull ; John Kiely ; Michael Griffith, Linked peptide nucleic acids.
  132. Mirkin, Chad A.; Nguyen, Sonbinh T.; Banga, Resham Singh; Chernyak, Natalia; Gryaznov, Sergei; Radovic-Moreno, Aleksandar; Mader, Christopher, Liposomal particles, methods of making same and uses thereof.
  133. Mirkin, Chad A.; Calabrese, Colin Michael; Morris, William, Metal-ligand coordination polymer nanoparticles and methods for making.
  134. Korfhage, Christian; Löffert, Dirk, Method for activating a nucleic acid for a polymerase reaction.
  135. Zichi, Dominic; Wilcox, Sheri K.; Bock, Chris; Schneider, Daniel J.; Eaton, Bruce; Gold, Larry, Method for generating aptamers with improved off-rates.
  136. Zichi, Dominic; Wilcox, Sheri K.; Bock, Chris; Schneider, Daniel J.; Eaton, Bruce; Gold, Larry, Method for generating aptamers with improved off-rates.
  137. Eaton Bruce (Pullman WA), Method for palladium catalyzed carbon-carbon coupling and products.
  138. Wada, Takeshi; Shimizu, Mamoru, Method for the synthesis of phosphorus atom modified nucleic acids.
  139. Wada, Takeshi; Shimizu, Mamoru, Method for the synthesis of phosphorus atom modified nucleic acids.
  140. Gleave, Martin E.; Ischia, Joseph, Method for treatment of castration-resistant prostate cancer.
  141. Cedillo, Isaiah E.; Janczak, Darren; Weaver, Phillip Michael, Method of preparing oligomeric compounds using modified capping protocols.
  142. Makarov, Vladimir, Methods and compositions for isolating polynucleotides.
  143. Crooke, Rosanne M.; Graham, Mark J.; Freier, Susan M.; Lim, Marc; Dibble, Andrew, Methods and compositions for modulating apolipoprotein (a) expression.
  144. Makarov, Vladimir; Kurihara, Laurie, Methods and compositions for size-controlled homopolymer tailing of substrate polynucleotides by a nucleic acid polymerase.
  145. Breaker, Ronald R.; Blount, Kenneth F.; Puskarz, Izabela J.; Wickiser, John K., Methods and compositions related to the modulation of riboswitches.
  146. Bennett Clarence Frank ; Manoharan Muthiah ; Hebert Normand ; Bhat Balkrishen, Methods and compounds for tracking the biodistribution of macromolecule-carrier combinations.
  147. Prakash, Thazha P.; Swayze, Eric E.; Corey, David; Yu, Dongbo, Methods and compounds useful in conditions related to repeat expansion.
  148. Bennett, C. Frank; Freier, Susan M.; Pulst, Stefan M.; Scoles, Daniel R.; Hung, Gene, Methods for modulating Ataxin 2 expression.
  149. Verdine, Gregory L.; Meena; Iwamoto, Naoki; Butler, David Charles Donnell, Methods for the synthesis of functionalized nucleic acids.
  150. Grasso, Luigi; Liang, Shaohong; Nicolaides, Nicholas C.; Sass, Philip M., Methods of generating high-production of antibodies from hybridomas created by in vitro immunization.
  151. Grasso, Luigi; Liang, Shaohong; Nicolaides, Nicholas C.; Sass, Philip M., Methods of generating high-production of antibodies from hybridomas created by in vitro immunization.
  152. Burel, Sebastien, Methods of predicting toxicity.
  153. Brown, Larry R.; Giannoukakis, Nick; Trucco, Massimo, Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes.
  154. Prakash, Thazha P.; Seth, Punit P.; Manoharan, Muthiah; Swayze, Eric E.; Rajeev, Kallanthottathil G.; Zlatev, Ivan, Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefrom.
  155. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom.
  156. Prakash, Thazha P.; Seth, Punit P.; Swayze, Eric E., Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom.
  157. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  158. Bennett, C. Frank; Cowsert, Lex M.; Freier, Susan M., Modulation of CD40 expression.
  159. Dean Nicholas M. ; McKay Robert, Modulation of c-jun using inhibitors of protein kinase C.
  160. Bennett, C. Frank; Freier, Susan M.; MacLeod, Robert A.; Pandey, Sanjay K.; Thornton, Charles A.; Wheeler, Thurman; Cheng, Seng H.; Leger, Andrew; Wentworth, Bruce M., Modulation of dystrophia myotonica-protein kinase (DMPK) expression.
  161. Monia, Brett P.; Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP1 expression.
  162. Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP2 expression.
  163. Bhanot, Sanjay; Dobie, Kenneth W.; Jain, Ravi, Modulation of eIF4E-BP2 expression.
  164. Bhanot,Sanjay; Dobie,Kenneth W.; Jain,Ravi, Modulation of eIF4E-BP2 expression.
  165. Brown-Driver, Vickie L.; Jain, Ravi, Modulation of transthyretin expression.
  166. Freier, Susan M., Modulation of transthyretin expression.
  167. Monia, Brett P.; Freier, Susan M.; Siwkowski, Andrew M.; Guo, Shuling, Modulation of transthyretin expression.
  168. Doyle, Patrick S.; Pregibon, Daniel C., Multifunctional encoded particles for high-throughput analysis.
  169. Bornhop, Darryl J., Multiplexed interferometric detection system and method.
  170. Prakash, Thazha P.; Bhat, Balkrishin; Swayze, Eric E., N-substituted-aminomethylene bridged bicyclic nucleic acid analogs.
  171. Mirkin, Chad A.; Ko, Caroline H.; Stegh, Alexander; Giljohann, David A.; Luciano, Janina; Jensen, Samuel A., Nanoconjugates able to cross the blood-brain barrier.
  172. Wahlestedt, Claes, Natural antisense and non-coding RNA transcripts as drug targets.
  173. Bornhop, Darryl J.; Flowers, Robert A.; Miller, Esther Pesciotta, Nonaqueous backscattering interferometric methods.
  174. Lasken, Roger S.; Egholm, Michael; Alsmadi, Osama A., Nucleic acid amplification.
  175. Pregibon, Daniel C.; Stoner, Isaac; Windemuth, Andreas; Erps, Timothy, Nucleic acid detection and quantification by post-hybridization labeling and universal encoding.
  176. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight, Nucleic acid functionalized nanoparticles for therapeutic applications.
  177. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  178. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nanoparticles for therapeutic applications.
  179. Mirkin, Chad A.; Rosi, Nathaniel L.; Thaxton, C. Shad; Giljohann, David A., Nucleic acid functionalized nonoparticles for therapeutic applications.
  180. Verdine, Gregory L.; ., Meena; Iwamoto, Naoki, Nucleic acid prodrugs and methods of use thereof.
  181. Matulic-Adamic Jasenka ; Beigelman Leonid ; Karpeisky Alexander, Nucleoside analogs.
  182. Andrei P. Guzaev ; Phillip Dan Cook ; Muthiah Manoharan ; Balkrishen Bhat, Nucleosidic and non-nucleosidic folate conjugates.
  183. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen; Guzzaev, Andrei P., Nucleosidic and non-nucleosidic folate conjugates.
  184. Prakash, Thazha P.; Swayze, Eric E.; Lima, Walter F.; Kinberger, Garth A., Oligomer-conjugate complexes and their use.
  185. Esau, Christine; Swayze, Eric E.; Bhat, Balkrishen; Kinberger, Garth A., Oligomeric compounds and compositions for the use in modulation of microRNAs.
  186. Esau, Christine; Swayze, Eric E.; Bhat, Balkrishen; Kinberger, Garth A., Oligomeric compounds and compositions for the use in modulation of micrornas.
  187. Esau, Christine; Swayze, Eric E.; Bhat, Balkrishen; Kinberger, Garth A., Oligomeric compounds and compositions for the use in modulation of target nucleic acids.
  188. Swayze, Eric E.; Bhat, Balkrishen; Lima, Walter F.; Prakash, Thazha P.; Kinberger, Garth A., Oligomeric compounds and methods.
  189. Swayze, Eric E.; Bhat, Balkrishen; Lima, Walter F.; Prakash, Thazha P.; Kinberger, Garth A., Oligomeric compounds and methods.
  190. Bhat, Balkrishen; Dande, Prasad; Prakash, Thazha P.; Allerson, Charles; Swayze, Eric E.; Griffey, Richard H., Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation.
  191. Oestergaard, Michael; Swayze, Eric E.; Seth, Punit P., Oligomeric compounds comprising alpha-beta-constrained nucleic acid.
  192. Swayze, Eric E.; Siwkowski, Andrew M., Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity.
  193. Seth, Punit P.; Freier, Susan M.; Monia, Brett P.; Swayze, Eric E., Oligomeric compounds comprising bicyclic nucleosides and uses thereof.
  194. Freier, Susan M.; Swayze, Eric E., Oligomeric compounds comprising bicyclic nucleotides and uses thereof.
  195. Freier, Susan M.; Swayze, Eric E., Oligomeric compounds comprising bicyclic nucleotides and uses thereof.
  196. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucelosides and methods for their use.
  197. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucelosides and methods for their use.
  198. Swayze, Eric E.; Siwkowski, Andrew M.; Seth, Punit P.; Prakash, Thazha P., Oligomeric compounds comprising tricyclic nucleosides and methods for their use.
  199. Seth, Punit P.; Swayze, Eric E., Oligomeric compounds having at least one neutrally linked terminal bicyclic nucleoside.
  200. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen, Oligonucleotide analogs having modified dimers.
  201. Phillip Dan Cook ; Muthiah Manoharan ; Balkrishen Bhat, Oligonucleotide analogs having modified dimers.
  202. Moore,Max N.; Andrade,Mark; Carty,Recaldo; Scozzari,Anthony; Krotz,Achim, Oligonucleotide synthesis with alternative solvents.
  203. Cook, Phillip Dan; Manoharan, Muthiah; Bhat, Balkrishen, Oligonucleotide-folate conjugates.
  204. Manoharan, Muthiah, Oligonucleotides conjugated to protein-binding drugs.
  205. Manoharan,Muthiah; Mohan,Venkatraman; Cook,Phillip Dan; Kawasaki,Andrew M., Oligonucleotides having A-DNA form and B-DNA form conformational geometry.
  206. Crooke, Stanley T., Oligoribonucleotides and ribonucleases for cleaving RNA.
  207. Cook Phillip Dan, PNA-DNA-PNA chimeric macromolecules.
  208. Mirkin, Chad A.; Seferos, Dwight S.; Giljohann, David A., Particles for detecting intracellular targets.
  209. Mirkin, Chad A.; Seferos, Dwight; Giljohann, David A., Particles for detecting intracellular targets.
  210. Nielsen,Peter; Buchardt,Ole; Sonnechsen,Soren Holst; Lohse,Jesper; Egholm,Michael; Manoharan,Muthiah; Kiely,John; Griffith,Michael; Sprankle,Kelly, Peptide nucleic acid conjugates.
  211. Michael Egholm ; Peter Nielsen DK; Ole Buchardt DK; Kim L. Dueholm DK; Leif Christensen DK; James M. Coull ; John Kiely ; Michael Griffith, Peptide nucleic acids.
  212. Nielsen Peter E.,DKX ; Buchardt Ole,DKX ; Egholm Michael,DKX ; Berg Rolf H.,DKX, Peptide nucleic acids.
  213. Ecker David J. ; Buchardt Ole,DKX ; Egholm Michael,DKX ; Nielsen Peter E.,DKX ; Berg Rolf H.,DKX ; Mollegaard Niels E.,DKX, Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand.
  214. Anantharamaiah, Gattadahalli M.; Fogelman, Alan M.; Navab, Mohamad; Rudolf, Martin, Peptides and peptide mimetics to treat pathologies associated with eye disease.
  215. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight S.; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  216. Mirkin, Chad A.; Giljohann, David A.; Seferos, Dwight; Prigodich, Andrew E.; Patel, Pinal C., Polyvalent RNA-nanoparticle compositions.
  217. Bhat, Balkrishen; Swayze, Eric E.; Prakash, Thazha P.; Allerson, Charles; Dande, Prasad; Griffey, Richard H., Positionally modified siRNA constructs.
  218. Song,Quanlai; Ross,Bruce S., Protection of nucleosides.
  219. Kirschenheuter Gary P. ; Eaton Bruce, Pyrimidine nucleosides as therapeutic and diagnostic agents.
  220. Allen, Nadia; Qiu, Peter, Quantitative helicase assay.
  221. Wooddell, Christine I.; Rozema, David B.; Lewis, David L.; Wakefield, Darren H.; Almeida, Lauren J., RNAi Therapy for Hepatitis B Virus Infection.
  222. Korfhage, Christian; Peist, Ralf; Löffert, Dirk, Reverse transcription and amplification of RNA with simultaneous degradation of DNA.
  223. Breaker, Ronald R.; Nahvi, Ali; Sudarsan, Narasimhan; Ebert, Margaret S.; Winkler, Wade; Barrick, Jeffrey E.; Wickiser, John K., Riboswitches, methods for their use, and compositions for use with riboswitches.
  224. Breaker, Ronald R.; Nahvi, Ali; Sudarsan, Narasimhan; Ebert, Margaret S.; Winkler, Wade; Barrick, Jeffrey E.; Wickiser, John K., Riboswitches, methods for their use, and compositions for use with riboswitches.
  225. Bornhop, Darryl J.; Kammer, Michael, Robust interferometer and methods of using same.
  226. Kumar, Gyanendra; Abarz?a, Patricio, Rolling circle amplification of RNA.
  227. Lizardi, Paul M., Rolling circle replication reporter systems.
  228. Pregibon, Daniel C.; Marini, Davide M.; Stoner, Isaac; Windemuth, Andreas; Erps, Timothy, Scanning multifunctional particles.
  229. Mirkin, Chad A.; Hurst, Sarah J.; Han, Min Su; Lytton-Jean, Abigail K. R., Screening sequence selectivity of oligonucleotide-binding molecules using nanoparticle based colorimetric assay.
  230. Seth, Punit P.; Oestergaard, Michael; Swayze, Eric E., Selective antisense compounds and uses thereof.
  231. Bhanot, Sanjay; Geary, Richard S.; McKay, Robert; Monia, Brett P.; Seth, Punit P.; Siwkowski, Andrew M.; Swayze, Eric E.; Wancewicz, Edward, Short antisense compounds with gapmer configuration.
  232. Seth, Punit P.; Prakash, Thazha P.; Swayze, Eric E., Substituted 2′-amino and 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom.
  233. Prakash, Thazha P.; Swayze, Eric E., Substituted 2′-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom.
  234. Seth, Punit P.; Swayze, Eric E., Substituted alpha-L-bicyclic nucleosides.
  235. Cook,Phillip Dan; Kawasaki,Andrew Mamoru, Sugar modified oligonucleotides.
  236. Phillip Dan Cook, Sugar modified oligonucleotides.
  237. Cook Philip Dan ; Kawasaki Andrew M., Sugar modified oligonucleotides that detect and modulate gene expression.
  238. Anantharamaiah, Gattadahalli M.; Garber, David W.; Datta, Geeta; Handattu, Sheila P.; Mishra, Vinod K., Synthetic apolipoprotein E mimicking polypeptides and methods of use.
  239. Anantharamaiah, Gattadahalli M.; White, C. Roger; Gupta, Himanshu, Synthetic apolipoprotein E mimicking polypeptides and methods of use.
  240. Buchardt, Ole; Buchardt, D.; Egholm, Michael; Nielsen, Peter Eigil; Berg, Rolf Henrik, Synthetic procedures for peptide nucleic acids.
  241. Cowsert,Lex M.; Baker,Brenda F.; McNeil,John; Freier,Susan M.; Sasmor,Henri M.; Brooks,Douglas G.; Ohashi,Cara; Wyatt,Jacqueline R.; Borchers,Alexander H.; Vickers,Timothy A., System of components for preparing oligonucleotides.
  242. Seth, Punit P.; Prakash, Thazha P., Targeted therapeutic nucleosides and their use.
  243. Donald, Carlton D., Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy.
  244. Donald, Carlton D., Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy.
  245. Donald, Carlton D., Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy.
  246. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  247. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  248. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  249. Donald, Carlton D., Targeting PAX2 for the treatment of breast cancer.
  250. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  251. Mirkin, Chad A.; Giljohann, David A.; Daniel, Weston L.; Cutler, Joshua I.; Zhang, Ke; Zheng, Dan, Templated nanoconjugates.
  252. Prakash, Thazha P.; Swayze, Eric E., Tetrahydropyran nucleic acid analogs.
  253. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  254. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  255. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  256. Swayze, Eric E.; Siwkowski, Andrew M.; Bhat, Balkrishen; Prakash, Thazha P.; Allerson, Charles; Seth, Punit P., Tetrahydropyran nucleic acid analogs.
  257. Faghihi, Mohammad Ali; Coito, Carlos, Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF.
  258. Hanash, Samir M.; Rickman, David; Tyagi, Rachana; Zhu, Xiao-Xiang; Kish, Phillip, Treatments and markers for cancers of the central nervous system.
  259. Seth, Punit P.; Swayze, Eric E.; Hanessian, Stephen; Schroeder, Benjamin R.; Giacometti, Robert D.; Merner, Bradley L., Tricyclic nucleic acid analogs.
  260. Abarzúa, Patricio; Smelkova, Natalia; Sparkowski, Jason, Universal reagents for rolling circle amplification and methods of use.
  261. Gary P. Kirschenheuter ; Bruce Eaton, Urea nucleosides as therapeutic and diagnostic agents.
  262. Kirschenheuter Gary ; Eaton Bruce, Urea nucleosides as therapeutic and diagnostic agents.
  263. Kirschenheuter, Gary; Eaton, Bruce, Urea nucleosides as therapeutic and diagnostic agents.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로